Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on December 3, 2004
Molecular Human Reproduction 2005 11(1):29-34; doi:10.1093/molehr/gah133
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
11/1/29    most recent
gah133v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nishida, M.
Right arrow Articles by Miyakawa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishida, M.
Right arrow Articles by Miyakawa, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction vol. 11 no. 1 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Endometriotic cells are resistant to interferon-{gamma}-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis

Masakazu Nishida, Kaei Nasu1, Tami Ueda, Junichiro Fukuda, Noriyuki Takai and Isao Miyakawa

Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Hasama-machi, Oita 879-5593, Japan

1 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Hasama-machi, Oita 879-5593, Japan. Email: nasu{at}med.oita-u.ac.jp

In order to evaluate the involvement of cell proliferation and apoptosis in the pathogenesis of endometriosis, we investigated the effects of interferon-{gamma} (IFN-) on cell growth inhibition and apoptosis of cultured ovarian endometriotic cyst stromal cells (ECSC), eutopic endometrial stromal cells with endometriosis (ESCwE) and normal endometrial stromal cells (NESC) by modified methylthiazoletetrazolium assay, 5-bromo-2'-deoxyuridine incorporation assay and internucleosomal DNA fragmentation assay. The expression of apoptosis-related molecules and IFN-{gamma} receptor 1 was also examined in ECSC, ESCwE and NESC using western blot analysis. IFN-{gamma} significantly inhibited cell proliferation and DNA synthesis of ESCwE and NESC, and induced apoptosis of these cells. In contrast, IFN-{gamma} did not show apparent effects on the viable cell number, DNA synthesis, or apoptosis of ECSC. An up-regulated expression of Bcl-2 and Bcl-XL proteins was observed in ECSC in comparison with ESCwE and NESC, whereas the levels of Bax, Bad, Fas and Fas ligand proteins in ECSC were similar to those in ESCwE and NESC. IFN-{gamma} receptor 1 expression was detected in ECSC, ESCwE and NESC. Enhanced expression of anti-apoptotic molecules in the ectopic endometrial cells may contribute to the development of endometriosis by conferring resistance to cytokine-induced apoptosis and increasing the chance that these cells will survive and implant outside the uterus. Further investigations on the regulation of cell proliferation in both the endometriotic and the normal endometrium may be important for the elucidation of the pathogenesis of endometriosis.

Key words: apoptosis/Bcl-XL/Bcl-2/endometriosis/interferon-{gamma}/pathogenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
J. D. Wren, Y. Wu, and S.-W. Guo
A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium
Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Nasu, M. Nishida, T. Ueda, A. Yuge, N. Takai, and H. Narahara
Application of the nuclear factor-{kappa}B inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E16 - E23.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Podgaec, M.S. Abrao, J.A. Dias Jr, L.V. Rizzo, R.M. de Oliveira, and E.C. Baracat
Endometriosis: an inflammatory disease with a Th2 immune response component
Hum. Reprod., May 1, 2007; 22(5): 1373 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Yuge, K. Nasu, H. Matsumoto, M. Nishida, and H. Narahara
Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis
Hum. Reprod., April 1, 2007; 22(4): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.-H. Yang, M.-Y. Wu, C.-D. Chen, M.-J. Chen, Y.-S. Yang, and H.-N. Ho
Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis
Hum. Reprod., April 1, 2007; 22(4): 945 - 952.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Nishida, K. Nasu, T. Ueda, A. Yuge, N. Takai, and H. Narahara
beta-Hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study
Hum. Reprod., November 1, 2006; 21(11): 2850 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Nasu, M. Nishida, T. Ueda, N. Takai, S. Bing, H. Narahara, and I. Miyakawa
Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis
Mol. Hum. Reprod., November 1, 2005; 11(11): 817 - 823.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.